This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Cancer Research Technology Limited. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Emma Jane Welsh - Innovator in Therapeutic Compounds
Introduction
Emma Jane Welsh is a notable inventor based in Sutton, GB. She has made significant contributions to the field of therapeutic compounds, particularly in the development of innovative oxy-phenyl-aryl compounds. Her work focuses on inhibiting Checkpoint Kinase 2 (CHK2) kinase function, which is crucial in the treatment of various proliferative conditions, including cancer.
Latest Patents
Emma Jane Welsh holds 1 patent for her invention titled "Therapeutic oxy-phenyl-aryl compounds and their use." This patent describes compounds that inhibit CHK2 kinase function and outlines their potential applications in pharmaceutical compositions. The compounds can be used both in vitro and in vivo to treat diseases mediated by CHK2, offering new avenues for cancer treatment.
Career Highlights
Emma is associated with Cancer Research Technology Limited, where she continues to advance her research in therapeutic compounds. Her innovative approach has positioned her as a key figure in the development of new cancer therapies.
Collaborations
Emma has collaborated with notable colleagues, including Antony William Oliver and Tony Michael Raynham, contributing to the advancement of research in her field.
Conclusion
Emma Jane Welsh's work in therapeutic compounds represents a significant advancement in cancer treatment. Her innovative research continues to pave the way for new therapeutic strategies.